Sign In
Buy CTMX
$3.22
+0.0600 (+1.90%)
At Close: Jun 03, 2026
Why Is CytomX Therapeutics (CTMX) Stock Up 29% Today?
10:47am, Thursday, 17'th Nov 2022
CytomX Therapeutics (NASDAQ: CTMX ) stock is rising higher on Wednesday after announcing a partnership with Regeneron Pharmaceuticals (NASDAQ: REGN ). This strategic partnership will see the two compa
CytomX Therapeutics, Inc. (CTMX) Q3 2022 Earnings Call Transcript
10:54pm, Tuesday, 08'th Nov 2022
CytomX Therapeutics, Inc. (NASDAQ:CTMX ) Q3 2022 Earnings Conference Call November 8, 2022 5:00 PM ET Company Participants Chris Ogden - SVP of Finance and Accounting Sean McCarthy - CEO and Chairman
CytomX Therapeutics (CTMX) Reports Q3 Loss, Misses Revenue Estimates
06:48pm, Tuesday, 08'th Nov 2022
CytomX Therapeutics (CTMX) delivered earnings and revenue surprises of -9.38% and 9.20%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
- IND filing for CX-801 is anticipated in the second half of 2023 - - IND filing for CX-801 is anticipated in the second half of 2023 -
CytomX Therapeutics to Present at Upcoming November Investor Conferences
04:15pm, Wednesday, 02'nd Nov 2022
SOUTH SAN FRANCISCO, Calif., Nov. 02, 2022 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of conditionally activated oncology therapeutics, today announced that Se
CytomX Therapeutics to Report Third Quarter 2022 Financial Results on November 8, 2022
08:00am, Tuesday, 01'st Nov 2022
SOUTH SAN FRANCISCO, Calif., Nov. 01, 2022 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of conditionally activated oncology therapeutics, today announced that it
CytomX Therapeutics, Inc. (CTMX) CEO Sean McCarthy on Q2 2022 Results - Earnings Call Transcript
08:40pm, Friday, 05'th Aug 2022
CytomX Therapeutics, Inc. (NASDAQ:CTMX ) Q2 2022 Earnings Conference Call August 4, 2022 5:00 PM ET Company Participants Chau Cheng - Vice President of Investor Relations & Corporate Communications Se
CytomX Therapeutics (CTMX) Reports Q2 Loss, Lags Revenue Estimates
06:48pm, Thursday, 04'th Aug 2022
CytomX Therapeutics (CTMX) delivered earnings and revenue surprises of -2.78% and 1.42%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
CytomX Therapeutics to Present at Upcoming Virtual August Investor Conferences
08:00am, Wednesday, 03'rd Aug 2022
SOUTH SAN FRANCISCO, Calif., Aug. 03, 2022 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of conditionally activated oncology therapeutics, today announced that
CytomX Therapeutics Cuts Workforce, Extend Cash Runway Into 2025
06:11am, Thursday, 14'th Jul 2022
CytomX Therapeutics Inc (NASDAQ: CTMX) is restructuring its business to prioritize internal investments in its emerging pre-clinical and early clinical pipeline. The company will cut 40% of its wor
CytomX Therapeutics Provides Strategic Update
08:05pm, Wednesday, 13'th Jul 2022 GlobeNewswire Inc.
- Company to focus internal efforts on wholly-owned next-generation conditionally activated therapeutics, including IFN alpha-2b cytokine and EpCAM-directed ADC, INDs planned for 2023 -
Benzinga's Top Ratings Upgrades, Downgrades For July 11, 2022
03:53pm, Monday, 11'th Jul 2022 Benzinga
Upgrades
For Visteon Corp (NASDAQ:VC), Exane BNP Paribas upgraded the previous rating of Neutral to Outperform. For the first quarter, Visteon had an EPS of $1.09, compared to year-ago quarter EPS of
This Low-Float Stock Jumps Around 148%; Here's 64 Biggest Movers From Yesterday
08:15am, Friday, 08'th Jul 2022 Benzinga
Gainers
United Maritime Corporation (NASDAQ: USEA) climbed 147.6% to close at $7.08 on Thursday on heavy momentum following the company's recent listing on the Nasdaq Capital Market.
Grove Collabora
Nasdaq Surges 250 Points; Crude Oil Rises Sharply
07:01pm, Thursday, 07'th Jul 2022 Benzinga
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite jumping 250 points following the release of data on initial jobless claims.
The Dow traded up 1.04% to 31,359.65 while th
Dow Jumps More Than 200 Points; Samsung Sees This Much Surge In Quarterly Revenue
04:11pm, Thursday, 07'th Jul 2022 Benzinga
U.S. stocks traded higher midway through trading, with the Dow Jones jumping more than 200 points following the release of data on initial jobless claims.
The Dow traded up 0.77% to 31,275.90 while th
